Cytochrome P450 Induction through the Efficient Photoinduced Release of a Pyridine-Substituted Agent from Ru(II)
- 18 September 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (39) , 35198-35202
Abstract
We report the first example of using photoinduced ligand release from a Ru(II) complex for light-triggered cytochrome P450 (CYP) induction. CYPs are pivotal enzymes in biosynthesis and drug metabolism, and their induction can be leveraged for therapeutics and biochemical research. We show the activation of a CYP1A1 with visible light through the efficient photorelease of an aryl hydrocarbon receptor (AHR; 1) agonist with a quantum yield, Φ500, of 0.16(1) with λirr = 500 nm in [Ru(tpy)(Me2bpy)(1)]2+ (tpy = 2,2':6',2″-terpyridine, Me2bpy = 6,6'-dimethyl-2,2'-bipyridine). This value is consistent with that previously reported for pyridine (py) exchange in the analogous [Ru(tpy)(Me2bpy)(py)]2+ complex, Φ500 = 0.16(1), which is driven by steric effects. In contrast to [Ru(tpy)(bpy)(py)]2+ (bpy = 2,2'-bipyridine), with Φ500 < 10-4, the ligand photodissociation in [Ru(tpy)(bpy)(1)]2+ proceeds with Φ500 = 0.015(1), at least 2 orders of magnitude more efficiently. Similarly, [Ru(tpy)(biq)(1)]2+ (4; biq = 2,2'-biquinoline) undergoes photoinduced exchange of 1 with CH3CN solvent with Φ500 = 0.064(3), more efficiently than [Ru(tpy)(biq)(py)]2+ with Φ500 = 0.03. Through experiments and calculations, we show the involvement of intraligand charge transfer (ILCT) within the leaving ligand in an unprecedented mechanism for ligand photodissociation from Ru(II). Chemical tools based on these findings hold the promise of advancing research on tissue-specific CYP activity by enabling precise spatiotemporal control. Moreover, these compounds may pave the way for the development of highly specific and light-activated pharmaceuticals that enhance the synergy with existing drugs.Keywords
Funding Information
- Division of Chemistry (2044648, 2349617)
- Wayne State University
This publication has 30 references indexed in Scilit:
- Mixed Ru(II)–Ir(III) Complexes as Photoactive Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4Inorganic Chemistry, 2024
- Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated ChemotherapyJournal of Medicinal Chemistry, 2024
- Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and PhotochemotherapyInorganic Chemistry, 2024
- Red‐Light Activation of a Microtubule Polymerization Inhibitor via Amide Functionalization of the Ruthenium PhotocageAngewandte Chemie International Edition, 2023
- Inhibition and induction of CYP enzymes in humans: an updateArchives of Toxicology, 2020
- Toward Optimal Ru(II) Photocages: Balancing Photochemistry, Stability, and Biocompatibility Through Fine Tuning of Steric, Electronic, and Physiochemical FeaturesInorganic Chemistry, 2020
- New Ru(II) Complexes for Dual Photoreactivity: Ligand Exchange and 1O2 GenerationAccounts of Chemical Research, 2015
- Human Cytochrome P450 and Personalized Medicine2014
- Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells: Role of the proximal promoter GC-rich regionBiochemical Pharmacology, 2012
- Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubinBiochemical Pharmacology, 2003